Longboard Pharmaceuticals, Inc.
·
LBPH
NASDAQ
·
Market ClosedTuesday, May 20, 2025
Change
Financial Profile
Prev Close
Market Cap
$2.34B
Day Range
$59.98 - $59.98
Open
P/E Ratio
-26.7
52W Range
$59.98 - $59.98
24H Volume
Dividend Yield
0.00%
EPS
-2.25
Income Statement
Revenue
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Cost of Revenue | $0 | $1K | $5K | $5K |
Gross Profit | $0 | -$1K | -$5K | -$5K |
Gross Profit % | 0% | 0% | 0% | 0% |
R&D Expenses | $4.6M | $20M | $35M | $44M |
Cash Flow
Net Income
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
Net Income | -$14M | -$28M | -$44M | -$54M |
Dep. & Amort. | $0 | $1K | $5K | $5K |
Def. Tax | $0 | $0 | $0 | $0 |
Stock Comp. | $8.5M | $2M | $2.7M | $3.3M |
Chg. in WC | $2.5M | $967K | $3.1M | $1.3M |
Balance Sheet
Cash
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
Cash | $55M | $66M | $11M | $14M |
ST Investments | $0 | $40M | $57M | $34M |
Cash & ST Inv. | $55M | $107M | $68M | $48M |
Receivables | $0 | $0 | $0 | $0 |
Inventory | $0 | $0 | $0 | $0 |
Related
Financial information provided by Financial Modeling Prep. Options data provided by Unusual Whales. Live transcripts provided by Quartr. Reported revenue and EPS data from Earnings powered by FinChat.io. All data is provided for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice.
- Market Cap
- $2.3B
- IPO Date
- 3/12/21
- CEO
- Mr. Kevin R. Lind
- Fulltime Employees
- 50
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- US
- Exchange
- NASDAQ Global Market
Peers
Molecular Partners AG$3.95$3.95
MOLN
+2.86%2.86%
MediciNova, Inc.$1.40$1.40
MNOV
+6.06%6.06%
Anebulo Pharmaceuticals, Inc.$1.06$1.06
ANEB
+3.92%3.92%
Champions Oncology, Inc.$5.92$5.92
CSBR
-6.77%6.77%
Cyteir Therapeutics, Inc.$3.02$3.02
CYT
-2.27%2.27%
Werewolf Therapeutics, Inc.$1.12$1.12
HOWL
+0.9%0.9%
Edgewise Therapeutics, Inc.$14.79$14.79
EWTX
+0.07%0.07%
Decibel Therapeutics, Inc.$4.91$4.91
DBTX
-0.81%0.81%
Celcuity Inc.$10.69$10.69
CELC
+0.75%0.75%
C4 Therapeutics, Inc.$1.54$1.54
CCCC
+11.59%11.59%
Assembly Biosciences, Inc.$13.80$13.80
ASMB
+2.83%2.83%
NextCure, Inc.$0.45$0.45
NXTC
+2.74%2.74%
Nuvation Bio Inc.$2.30$2.30
NUVB
+1.77%1.77%
Graphite Bio, Inc.$3.18$3.18
GRPH
-2.75%2.75%
Instil Bio, Inc.$16.90$16.90
TIL
+15.52%15.52%
Sensei Biotherapeutics, Inc.$0.33$0.33
SNSE
-4.62%4.62%
Merrimack Pharmaceuticals, Inc.$15.15$15.15
MACK
+0.1%0.1%
Monte Rosa Therapeutics, Inc.$4.11$4.11
GLUE
+3.27%3.27%
Design Therapeutics, Inc.$3.53$3.53
DSGN
+0.57%0.57%
Ikena Oncology, Inc.$1.11$1.11
IKNA
+0.9%0.9%
Stoke Therapeutics, Inc.$9.83$9.83
STOK
+0.72%0.72%